Resting-State Isolated Effective Connectivity of the Cingulate Cortex as a Neurophysiological Biomarker in Patients with Severe Treatment-Resistant Schizophrenia
- Supplementary File 1:
PDF-Document (PDF, 213 KiB)
Wada, M.; Nakajima, S.; Tarumi, R.; Masuda, F.; Miyazaki, T.; Tsugawa, S.; Ogyu, K.; Honda, S.; Matsushita, K.; Kikuchi, Y.; Fujii, S.; Blumberger, D.M.; Daskalakis, Z.J.; Mimura, M.; Noda, Y. Resting-State Isolated Effective Connectivity of the Cingulate Cortex as a Neurophysiological Biomarker in Patients with Severe Treatment-Resistant Schizophrenia. J. Pers. Med. 2020, 10, 89. https://doi.org/10.3390/jpm10030089
Wada M, Nakajima S, Tarumi R, Masuda F, Miyazaki T, Tsugawa S, Ogyu K, Honda S, Matsushita K, Kikuchi Y, Fujii S, Blumberger DM, Daskalakis ZJ, Mimura M, Noda Y. Resting-State Isolated Effective Connectivity of the Cingulate Cortex as a Neurophysiological Biomarker in Patients with Severe Treatment-Resistant Schizophrenia. Journal of Personalized Medicine. 2020; 10(3):89. https://doi.org/10.3390/jpm10030089
Chicago/Turabian StyleWada, Masataka, Shinichiro Nakajima, Ryosuke Tarumi, Fumi Masuda, Takahiro Miyazaki, Sakiko Tsugawa, Kamiyu Ogyu, Shiori Honda, Karin Matsushita, Yudai Kikuchi, Shinya Fujii, Daniel M. Blumberger, Zafiris J. Daskalakis, Masaru Mimura, and Yoshihiro Noda. 2020. "Resting-State Isolated Effective Connectivity of the Cingulate Cortex as a Neurophysiological Biomarker in Patients with Severe Treatment-Resistant Schizophrenia" Journal of Personalized Medicine 10, no. 3: 89. https://doi.org/10.3390/jpm10030089